Atıf İçin Kopyala
AKAY A., ÇAPA KAYA G., Kose S., ERESEN YAZICIOĞLU Ç., Erkuran H. O., ALŞEN GÜNEY S., ...Daha Fazla
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, cilt.86, ss.294-300, 2018 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
86
-
Basım Tarihi:
2018
-
Doi Numarası:
10.1016/j.pnpbp.2018.04.008
-
Dergi Adı:
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.294-300
-
Anahtar Kelimeler:
ADHD, DAT1 gene, [Tc-(99m)] TRODAT-1 SPECT, OROS-methylphenidate, DEFICIT HYPERACTIVITY DISORDER, DOPAMINE-TRANSPORTER GENE, ATTENTION-DEFICIT/HYPERACTIVITY DISORDER, TC-99M-TRODAT-1 SPECT, PARKINSONS-DISEASE, CHILDREN, ASSOCIATION, ADULTS, PSYCHOSTIMULANTS, AVAILABILITY
-
Dokuz Eylül Üniversitesi Adresli:
Evet
Özet
Aim: To examine theeffects on the brain of 2-month treatment withamethylphenidate extended-release formulation (OROS-MPH) using [Tc-(99m)] TRODAT-1SPECT in a sample of treatment-naive adolescents with Attention Deficit/Hyperactivity Disorder (ADHD). In addition, to assess whether risk alleles (homozygosity for 10-repeat allele at the DAT1 gene were associated with alterations in striatal DAT availability.